Similarly, activated STING has been shown to be released in the extracellular vesicles of tumor cells stimulated with a STING agonist, and these extracellular vesicles were shown to promote anti-tumor immunity in mouse tumor models (Gao et al., 2022). This evidence concerns the gene STING1 and neoplasm.